1. Expression of microRNA‑184 in glioma
    Xiao‑Ben Wu et al, 2017, Oncology Letters CrossRef
  2. Cripto-1 promotes resistance to drug-induced apoptosis by activating the TAK-1/NF-κB/survivin signaling pathway
    YingYu Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  3. Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers
    Annamaria Sandomenico et al, 2019, Current Medicinal Chemistry CrossRef
  4. Prognostic value of cripto-1 expression in non-small-cell lung cancer patients: a systematic review and meta-analysis
    Yuanfeng Wei et al, 2020, Biomarkers in Medicine CrossRef
  5. A Multidisciplinary Review of the Roles of Cripto in the Scientific Literature Through a Bibliometric Analysis of its Biological Roles
    Elisa Rodrigues Sousa et al, 2020, Cancers CrossRef
  6. Micro RNAs as a Diagnostic Marker between Glioma and Primary CNS Lymphoma: A Systematic Review
    Mohammad Amin Dabbagh Ohadi et al, 2023, Cancers CrossRef
  7. MicroRNA‐622 suppresses the proliferation of glioma cells by targeting YAP1
    Jin Xu et al, 2018, Journal of Cellular Biochemistry CrossRef
  8. Knockdown of Cripto-1 inhibits the proliferation, migration, invasion, and angiogenesis in prostate carcinoma cells
    Ding Wu et al, 2017, Journal of Biosciences CrossRef
  9. Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
    Chunxiao Hu et al, 2021, Frontiers in Oncology CrossRef
  10. Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal
    David W. Freeman et al, 2021, International Journal of Molecular Sciences CrossRef
  11. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway
    Regina Cheuk-Lam Lo et al, 2018, Cell Death & Differentiation CrossRef
  12. Advanced Lab-on-Fiber Optrodes Assisted by Oriented Antibody Immobilization Strategy
    Sarassunta Ucci et al, 2022, Biosensors CrossRef
  13. Understanding the role of Cripto-1 in cancer progression and therapeutic strategies
    Qingfang Zeng et al, 2022, Clinical and Translational Oncology CrossRef
  14. Epigenetics and personalized medicine of brain cancer
    George I. Lambrou, 2022, Epigenetics in Precision Medicine CrossRef
  15. Teratocarcinoma-derived growth factor-1 (Cripto-1) is overexpressed in epithelial odontogenic lesions displaying more aggressive behaviour
    Leorik Pereira da Silva et al, 2020, Oral and Maxillofacial Surgery CrossRef
  16. Cripto-1 is overexpressed in carcinoma ex pleomorphic adenoma of salivary gland
    Leorik Pereira Silva et al, 2018, European Archives of Oto-Rhino-Laryngology CrossRef
  17. New Insights into Cancer Targeted Therapy: Nodal and Cripto-1 as Attractive Candidates
    Paola Arboretto et al, 2021, International Journal of Molecular Sciences CrossRef
  18. miR-3929 Inhibits Proliferation and Promotes Apoptosis by Downregulating Cripto-1 Expression in Cervical Cancer Cells
    Ying Wang et al, 2021, Cytogenetic and Genome Research CrossRef
  19. MicroRNA-15b Deteriorates Hypoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis by Downregulating Bcl-2 and MAPK3
    Yaling Liu et al, 2018, Journal of Investigative Medicine CrossRef